Interferon α-2b Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Interferon α-2b is U.S. Food and Drug Administration (FDA) approved for the treatment of stage IIB and stage III disease. Treatment for 1 year resulted in a prolonged survival (2.8 years compared with 3.8 years and prolongation of disease-free survival from 1.0 to 1.7 years). The Sunbelt Melanoma Trial is under way and will attempt to answer the benefit of interferon therapy and the significance of lymph nodes that are positive only by PCR analysis.

Interferon α-2b Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Interferon α-2b Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Sangon Biotech (Shanghai) Co., Ltd.	--	market3@sangon.com	CHINA	6951	58
A.T.CHEMICAL	--	Jeffreyxu@atchem.net	China	6589	51

---

• Interferon α-2b
• human IFN-α2b (E. coli-derived)